Patents Assigned to Fibrosoft Pte Ltd
  • Tissue Modifier And Uses Therefor
    Publication number: 20250276048
    Abstract: Disclosed are compositions, methods, uses, kits and articles of manufacture, which are based on the use of a hyaluronidase and a collagen-reducing agent, for reducing or inhibiting the development of fibrosis in a tissue, or for treating collagen-mediated disorders. In specific embodiments, the collagen-mediated disorders are fibroproliferative disorders involving alterations of collagen, including fibromatoses such as Dupuytren's disease, Peyronie's disease and Ledderhose's disease.
    Type: Application
    Filed: March 19, 2025
    Publication date: September 4, 2025
    Applicant: Fibrosoft Pte Ltd
    Inventor: David Chin
  • Tissue modifier and uses therefor
    Patent number: 12280095
    Abstract: Disclosed are compositions, methods, uses, kits and articles of manufacture, which are based on the use of a hyaluronidase and a collagen-reducing agent, for reducing or inhibiting the development of fibrosis in a tissue, or for treating collagen-mediated disorders. In specific embodiments, the collagen-mediated disorders are fibroproliferative disorders involving alterations of collagen, including fibromatoses such as Dupuytren's disease. Peyronie's disease and Ledderhose's disease.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: April 22, 2025
    Assignee: Fibrosoft Pte Ltd
    Inventor: David Chin